{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:27:10Z","timestamp":1746214030744},"reference-count":45,"publisher":"Czech Society of Ophthalmology of the CzMA","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CSO"],"published-print":{"date-parts":[[2021,11,25]]},"abstract":"<jats:p>Subjective and objective symptoms following intraocular lymphoma could lead to a misdiagnosing at the beginning of disease what is the cause for delay of an effective treatment. The most common manifestation of lymphoma is an inflammatory disease affecting uvea. A multidisciplinary approach to the diagnosis is required. Suspicion based on the ophthalmologic examinations has to be verified by histology. We present a case report of a 78-year-old patient examined at our clinic with progressive loss of vision on the left eye in 6 months, suspected of retinal detachment. Objectively the visual acuity was counting fingers in front of the left eye. Intraocular pressure changed from normotensive into hypertensive values during regular examinations. We realised imaging exams, ultrasonography and magnetic resonance, which proved intraocular tumour with retrobulbar infiltration and retinal detachment. The patient was indicated for enucleation which enabled assignment of a histologic type of intraocular lymphoma B-Non-Hodgkin lymphoma from marginal zone B-cells. We sent the patient to a haematologist-oncologist for managing of the following treatment and we prescribed individual prosthesis to the patient after the enucleation. The patient remains in observation, no surgical treatment, chemotherapy or radiotherapy have been used for 23 months after the enucleation. The enucleation was both a diagnostic and treatment modality.<\/jats:p>","DOI":"10.31348\/2021\/37","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:44:17Z","timestamp":1657719857000},"page":"306-311","source":"Crossref","is-referenced-by-count":1,"title":["Intraocular Lymphoma with Retrobulbar Infiltration. A Case Report"],"prefix":"10.31348","volume":"77","author":[{"given":"Denisa","family":"Jurenov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul\u00edna","family":"Plesn\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darina","family":"Lyskov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Bab\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Kobzov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Furdov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16213","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008 Aug;36(6):564-578. doi: 10.1111\/j.1442-9071.2008.01843.x","DOI":"10.1111\/j.1442-9071.2008.01843.x"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Tang L-J, Gu C-L, Zhang P. Incraocular lymphoma. Int J Ophthalmol. 2017;10(8):1301-1307. doi: 10.18240\/ijo.2017.08.19","DOI":"10.18240\/ijo.2017.08.19"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014 Sep-Oct;59(5):503-516. doi: 10.1016\/j.survophthal.2013.12.001","DOI":"10.1016\/j.survophthal.2013.12.001"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Reddy EK, Bhatia P, Evans RG. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys. 1988 Nov;15(5):1239-1241. doi: 10.1016\/0360-3016(88)90210-6","DOI":"10.1016\/0360-3016(88)90210-6"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Cho B-J, Yu HG. Risk factors for intraocular involvement in patients with primary central nervous system lymphoma. J Neurooncol. 2014 Dec;120(3):523-529. doi: 10.1007\/s11060-014-1581-4","DOI":"10.1007\/s11060-014-1581-4"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Sobrin L, Dubovy SR, Davis JL, Murray TG. Isolated, bilateral intraocular lymphoma in a 15-year-old girl. Retina. 2005 Apr-May;25(3):370-373. doi: 10.1097\/00006982-200504000-00021","DOI":"10.1097\/00006982-200504000-00021"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Wender A. Primary B-Cell Lymphoma of the Eyes and Brain in a 3-Year-Old Boy. Arch Ophthalmol. 1994 Apr;112(4):450-451. doi: 10.1001\/archopht.1994.01090160024009","DOI":"10.1001\/archopht.1994.01090160024009"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Chan S. Iris lymphoma in a pediatric cardiac transplant recipient Clinicopathologic findings. Ophthalmology. 2000 Aug;107(8):1479-1482. doi: 10.1016\/s0161-6420(00)00172-x","DOI":"10.1016\/s0161-6420(00)00172-x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Berenbom A, Davila RM, Lin H-S, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye. 2007 Sep;21(9):1198-1201. doi: 10.1038\/sj.eye.6702437","DOI":"10.1038\/sj.eye.6702437"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Buettner H, Bolling JP. Intravitreal Large-Cell Lymphoma. Mayo Clin Proc. 1993 Oct;68(10):1011-1015. doi: 10.1016\/s0025-6196(12)62276-9","DOI":"10.1016\/s0025-6196(12)62276-9"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993 Aug;72(3):843-849. doi: 10.1002\/1097-0142(19930801)72:3<843: aid-cncr2820720333>3.0.co;2-#","DOI":"10.1002\/1097-0142(19930801)72:3<843::aid-cncr2820720333>3.0.co;2-#"},{"key":"ref11","unstructured":"Furdov\u00e1 A, Markov\u00e1 A, Kapit\u00e1nov\u00e1 K, Zahorjanov\u00e1 P. Treatment results in patients with lymphoma disease in the orbital region. Cesk Slov Oftalmol. 2017;73(5-6):211-217. Available from: http:\/\/www.cs-ophthalmology.cz\/en\/journal\/articles\/32"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Melson MR, Mukai S. Intraocular Lymphoma. Int Ophthalmol Clin. 2006;46(2):69-77. doi: 10.1097\/00004397-200604620-00008","DOI":"10.1097\/00004397-200604620-00008"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993 Sep;100(9):1399-1406. doi: 10.1016\/s0161-6420(93)31469-7","DOI":"10.1016\/s0161-6420(93)31469-7"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Chan C-C, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002 Dec;13(6):411-418. doi: 10.1097\/00055735-200212000-00012","DOI":"10.1097\/00055735-200212000-00012"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):901-913. doi: 10.1007\/s00417-004-0973-0","DOI":"10.1007\/s00417-004-0973-0"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000 Dec;8(4):243-250. doi: 10.1076\/ocii.8.4.243.6463","DOI":"10.1076\/ocii.8.4.243.6463"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol. 2007 Nov;18(11):1851-1855. doi: 10.1093\/annonc\/mdm340","DOI":"10.1093\/annonc\/mdm340"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye. 2003 May;17(4):513-521. doi: 10.1038\/sj.eye.6700378","DOI":"10.1038\/sj.eye.6700378"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Batis V, Shuttleworth J, Shuttleworth G, Williams GS. Diagnostic dilemma of ocular lymphoma. BMJ Case Rep. 2019 Jun;12(6):e229513. doi: 10.1136\/bcr-2019-229513","DOI":"10.1136\/bcr-2019-229513"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Vosganian GS, Boisot S, Hartmann KI, et al. Primary intraocular lymphoma: a review. J Neurooncol. 2011 Nov;105(2):127-134. doi: 10.1007\/s11060-011-0618-1","DOI":"10.1007\/s11060-011-0618-1"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Bardenstein DS. Intraocular Lymphoma: Intraocular lymphoma is the most elusive intraocular tumor to diagnose. Cancer Control. 1998;5(4):317-325. doi: 10.1177\/107327489800500403","DOI":"10.1177\/107327489800500403"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Choi JY, Kafkala C, Foster CS. Primary Intraocular Lymphoma: A Review. Semin Ophthalmol. 2006;21(3):125-133. doi: 10.1080\/08820530500350498","DOI":"10.1080\/08820530500350498"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Dean JM, Novak MA, Chan CC, Green WR. Tumor detachments of the retinal pigment epithelium in ocular\/ central nervous system lymphoma. Retina. 1996;16(1):47-56. doi: 10.1097\/00006982-199616010-00009","DOI":"10.1097\/00006982-199616010-00009"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Fardeau C, Lee CPL, Merle-B\u00e9ral H, et al. Retinal Fluorescein, Indocyanine Green Angiography, and Optic Coherence Tomography in Non-Hodgkin Primary Intraocular Lymphoma. Am J Ophthalmol. 2009;147(5):886-894.e1. doi: 10.1016\/j.ajo.2008.12.025","DOI":"10.1016\/j.ajo.2008.12.025"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Garweg JG, Wanner D, Sarra G-M, et al. The diagnostic yield of vitrectomy specimen analysis in chronic idiopathic endogenous uveitis. Eur J Ophthalmol. 2006;16(4):588-594. doi: 10.1177\/112067210601600414","DOI":"10.1177\/112067210601600414"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Chan C-C, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11(5):285-295. doi: 10.1177\/107327480401100502","DOI":"10.1177\/107327480401100502"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):860-870. doi: 10.1007\/s00417-003-0749-y","DOI":"10.1007\/s00417-003-0749-y"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Cursiefen C. Holbach LM, Lafaut B, Heimann K, Kirchner T, Naumann GO. Oculocerebral Non-Hodgkin\u2019s Lymphoma With Uveal Involvement Development of an Epibulbar Tumor After Vitrectomy. Arch Ophthalmol. 2000;118(10):1437-1440. doi:10.1001\/archopht.118.10.1437","DOI":"10.1001\/archopht.118.10.1437"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Trudeau M, Shepherd FA, Blackstein ME, Gospodarowicz M, Fitzpatrick P, Moffatt KP. Intraocular lymphoma: report of three cases and review of the literature. Am J Clin Oncol. 1988;11(2):126-130.","DOI":"10.1097\/00000421-198804000-00008"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Faia LJ, Chan C-C. Primary intraocular lymphoma. Arch Pathol Lab Med. 2009;133(8):1228-1232. doi: 10.1043\/1543-2165-133.8.1228","DOI":"10.5858\/133.8.1228"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Mason JO, Fischer DH. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma. Ophthalmology. 2003;110(6):1241-1244. doi: 10.1016\/S0161-6420(03)00268-9","DOI":"10.1016\/s0161-6420(03)00268-9"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Sandor V, Stark-Vancs V, Pearson D, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol. 1998 Sep;16(9):3000-3006. doi: 10.1200\/JCO.1998.16.9.3000","DOI":"10.1200\/jco.1998.16.9.3000"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999 Apr;83(4):448-451. doi: 10.1136\/bjo.83.4.448","DOI":"10.1136\/bjo.83.4.448"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y. Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol. 2008;52(3):167-174. doi: 10.1007\/s10384-008-0519-9","DOI":"10.1007\/s10384-008-0519-9"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Itty S, Pulido JS. Rituximab for Intraocular Lymphoma: Retina. 2009 Feb;29(2):129-132. doi: 10.1097\/IAE.0b013e318192f574","DOI":"10.1097\/iae.0b013e318192f574"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye. 2007 Dec;21(12):1524-1527. doi: 10.1038\/sj.eye.6702804","DOI":"10.1038\/sj.eye.6702804"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Ohguro N, Hashida N, Tano Y. Effect of Intravitreous Rituximab Injections in Patients With Recurrent Ocular Lesions Associated With Central Nervous System Lymphoma. Arch Ophthalmol. 2008;126(7):1002-1003. doi: 10.1001\/archopht.126.7.1002","DOI":"10.1001\/archopht.126.7.1002"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Soussain C, Hoang-Xuan K, Levy V. Chimioth\u00e9rapie intensive avec support h\u00e9matopo\u00ef\u00e9tique chez 22 patients ayant un lymphome primitif du syst\u00e8me nerveux central ou un lymphome intraoculaire r\u00e9fractaire ou en rechute : mise \u00e0 jour des r\u00e9sultats [Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma]. Bull Cancer. 2004 Feb;91(2):189-192. French.","DOI":"10.1200\/jco.2001.19.3.742"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Abrey LE, Moskowitz CH, Mason WP, et al. Intensive Methotrexate and Cytarabine Followed by High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Newly Diagnosed Primary CNS Lymphoma: An Intent-to-Treat Analysis. J Clin Oncol. 2003 Nov;21(22):4151-4156. doi: 10.1200\/JCO.2003.05.024","DOI":"10.1200\/jco.2003.05.024"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Chow PP-C, Ho SL, Lai WW, Au WY. Enucleation of painful blind eye for refractory intraocular lymphoma after dose-limiting chemotherapy and radiotherapy. Ann Hematol. 2012;91(10):1657-1658. doi: https:\/\/doi.org\/10.1007\/s00277-012-1452-z","DOI":"10.1007\/s00277-012-1452-z"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Albadri ST, Pulido JS, Macon WR, Garcia JJ, Salomao DR. Histologic findings in vitreoretinal lymphoma: learning from enucleation specimens. Retina. 2020 Feb;40(2):391-398. doi: 10.1097\/IAE.0000000000002676","DOI":"10.1097\/iae.0000000000002676"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Burnier SV, Burnier MN. Linfoma sist\u00eamico de c\u00e9lulas B com manifesta\u00e7\u00e3o ocular e extens\u00e3o extraocular [Systemic B-cell lymphoma with ocular manifestation and extraocular extension]. Arq Bras Oftalmol. 1997;60(6). doi: 10.5935\/0004-2749.19970015","DOI":"10.5935\/0004-2749.19970015"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Sood AB, Yeh S, Mendoza P, Grossniklaus HE. Histopathologic Diagnosis of Atypical Primary Vitreoretinal Lymphoma following Enucleation. Ocul Oncol Pathol. 2016;2(4):242-245. doi: 10.1159\/000446605","DOI":"10.1159\/000446605"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal Lymphoma: Clinical Features, Diagnostic Studies, Treatment Selection, and Outcomes. Ophthalmology. 2014;121(1):334-41. doi: https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.004","DOI":"10.1016\/j.ophtha.2013.09.004"}],"container-title":["Czech and Slovak Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T13:44:45Z","timestamp":1657719885000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cs-ophthalmology.cz\/en\/journal\/articles\/225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.31348\/2021\/37","relation":{},"ISSN":["1805-4447","1211-9059"],"issn-type":[{"value":"1805-4447","type":"electronic"},{"value":"1211-9059","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}